Long-term morbidity of axillary lymph node dissection: implications for patients with carcinoma breast
- PMID: 23472425
Long-term morbidity of axillary lymph node dissection: implications for patients with carcinoma breast
Abstract
Background: To assess the long term complications of level II Axillary Lymph Node Dissection (AXLND) in patients with breast cancer and to see if they are high enough to warrant a Sentinel Lymph Node (SLN) biopsy in all patients presenting with carcinoma breast in our setup in Pakistan.
Methods: This study was conducted at Surgical Unit IV, Department of Surgery, Combined Military Hospital, Rawalpindi. Upper, lower arm circumferences and body mass index were ascertained in post Modified Radical Mastectomy (MRM) with level II AXLND, in female patients who had undergone surgeries from 1992 to 2008. Patient's perception of degree of lymph oedema, arm function and other symptoms like pain, tingling and numbness was noted. The number of lymph nodes removed, number of positive nodes and post operative radiotherapy were also recorded from the hospital records.
Results: Thus upper arm circumference in 85.7% patients and lower arm circumference in 89.2% patients was within 2 Cm of the unaffected side. No, moderate and severe arm swelling was described by 83.35% of patients, 11.6% of patients and one patient respectively and 41.5% of patients describing some arm swelling had positive lymph nodes. Thus even if they had gone (SLN) biopsy, these patients would have had a subsequent AXLND. Over 94% of patients had either good or excellent arm function with most in the excellent range.
Conclusion: The patients at significant risk for positive nodal may be better served with an AXLND rather than the SLN technique.
Similar articles
-
Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.Ann Surg. 2004 Jul;240(1):1-6. doi: 10.1097/01.sla.0000129358.80798.62. Ann Surg. 2004. PMID: 15213610 Free PMC article.
-
Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.Breast. 2008 Apr;17(2):138-47. doi: 10.1016/j.breast.2007.08.006. Epub 2007 Oct 24. Breast. 2008. PMID: 17928226
-
Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?Cancer. 2010 Apr 15;116(8):1987-91. doi: 10.1002/cncr.24964. Cancer. 2010. PMID: 20151427
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
MeSH terms
LinkOut - more resources
Medical